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MeCP2 is a transcriptional repressor critical
for normal neurological function. Prior studies
demonstrated that either loss or doubling of
MeCP2 results in postnatal neurodevelopmen-
tal disorders. To understand the impact of
MeCP2 expression on neuronal function, we
studied the synaptic properties of individual
neurons from mice that either lack or express
twice the normal levels ofMeCP2. Hippocampal
glutamatergic neurons that lack MeCP2 display
a 46% reduction in synaptic response, whereas
neurons with doubling of MeCP2 exhibit a
2-fold enhancement in synaptic response. Fur-
ther analysis shows that these changes were
primarily due to the number of synapses
formed. These results reveal that MeCP2 is
a key rate-limiting factor in regulating glutama-
tergic synapse formation in early postnatal
development and that changes in excitatory
synaptic strength may underlie global network
alterations in neurological disorders due to
altered MeCP2 levels.
INTRODUCTION
Classic Rett syndrome (RTT) is a progressive childhood
neurodevelopmental disorder due to loss of function muta-
tions in the X-linked gene encoding the transcriptional
repressor methyl-CpG binding protein 2 (MECP2) (Amir
et al., 1999). RTT is characterized by a period of apparently
normal development for 6–18 months followed by regres-
sion and onset of a variety of neurological features, including
tremors, seizures, stereotypies, mental retardation, loss of
motor skills, and autistic features (Hagberg et al., 1983;
Rett, 1966). Mutations in MECP2 also cause nonsyndromic
mental retardation, mild learning disability, and classic
autism (Carney et al., 2003; Couvert et al., 2001; Meloni
et al., 2000; Orrico et al., 2000). Duplications spanning
MECP2 result in twice the endogenous protein levels (Van58 Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc.Eschetal., 2005) and cause mental retardation and progres-
sive neurological symptoms with autistic features, seizures,
and loss of motor skills in males (del Gaudio et al., 2006;
Friez et al., 2006; Shi et al., 2005; Van Esch et al., 2005).
Mice either lacking MeCP2 (Mecp2Null/y) (Chen et al.,
2001; Guy et al., 2001) or carrying a truncated allele of
MeCP2 (Mecp2308/y) (Shahbazian et al., 2002) appear nor-
mal until 4–6 weeks of age, after which they display motor
impairments, seizures, forepaw stereotypies, hypoactiv-
ity, and premature lethality. Strikingly, mice with twice
the endogenous level of MeCP2 (Mecp2Tg1) also appear
normal until 10–12 weeks of age, after which they display
forepaw stereotypies, impaired coordination, seizures,
hypoactivity, and spasticity (Collins et al., 2004).
Electrophysiological studies of these mouse models
showed impairments in long-term synaptic plasticity and
excitatory drive. Reduced long-term potentiation (LTP)
was observed in Mecp2Null/y cortical slices (Asaka et al.,
2006) and in Mecp2308/y hippocampal slices (Moretti
et al., 2006). Enhanced LTP was observed in Mecp2Tg1
hippocampal slices (Collins et al., 2004). Additionally,
loss of MeCP2 results in reduced spontaneous activity in
cortical slices due to a reduction in the size of spontane-
ous excitatory postsynaptic currents (EPSCs) (Dani
et al., 2005). However, these studies did not reveal a mech-
anism by which MeCP2 regulates synaptic function at sin-
gle-neuron and network levels.
In order to examine the physiological consequences of
either loss or doubling of MeCP2, we utilized autaptic
hippocampal neurons (Bekkers and Stevens, 1991) from
Mecp2Null/y (Guy et al., 2001) and Mecp2Tg1 mice (Collins
et al., 2004) to minimize the potential confounding effects of
homeostatic processes. We discovered that MeCP2 regu-
latesglutamatergicsynapticdensity inhippocampalneurons,
providing a mechanism for the altered synaptic strength.
RESULTS
Loss or Doubling of MeCP2 Alters the Magnitude
of Evoked EPSCs and Frequency of Spontaneous
mEPSC Events
To study the overall impact of MeCP2 levels on synaptic
output, we examined action-potential-evoked excitatory
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dures). Analysis of evoked EPSCs from Mecp2Null/y neu-
rons revealed a 46% reduction in the EPSC amplitude
(Figures 1A and 1B) and from Mecp2Tg1 neurons revealed
a 116% enhancement of the EPSC size (Figures 1A and
1C) compared to respective WT. These findings show
that MeCP2 regulates the magnitude of synaptic output
at a single-cell level. The magnitude of the evoked EPSC
depends on the postsynaptic response to the release of
an individual vesicle (quantal size), the number of fusion-
competent vesicles (readily releasable pool [RRP]), and
the efficiency of the calcium-triggered fusion of synaptic
vesicles (vesicular release probability [Pvr]).
Quantal size depends on the amount of transmitters per
vesicle and the postsynaptic receptor. To assess quantal
size, we evaluated spontaneous non-calcium-dependent
neurotransmitter release in autaptic neurons, or miniature
excitatory postsynaptic current (mEPSC) events (see
Experimental Procedures). Our study revealed no signifi-
cant differences in mEPSC amplitude and decay time con-
stant for Mecp2Null/y and Mecp2Tg1 neurons (see Figures
S2A–S2D in the Supplemental Data available with this ar-
ticle online), indicating that the amount of transmitter per
vesicle and postsynaptic receptor responsiveness is unal-
tered. However, Mecp2Null/y neurons showed a significant
decrease in mEPSC frequency (Figures 1D and 1E), and
Mecp2Tg1 neurons showed a significant increase in
mEPSC frequency (Figures 1D and 1F) compared to
respective WT. This indicates that the number of fusion-
Figure 1. Loss or Doubling of MeCP2 Alters the Magnitude of
Evoked EPSCs and Frequency of Spontaneous mEPSC
Events
(A) Mean action-potential-evoked EPSC trace from data shown in (B)
and (C). Data collected at an earlier time point for Mecp2Tg1 neurons
to reduce voltage-clamp errors.
(B and C) Bar graphs show EPSC amplitude.
(D) Representative mEPSC traces with upper trace in the presence of 3
mM glutamate receptor blocker, kynurenic acid (Kyn).
(E and F) Bar graphs show mEPSC frequency. Number of neurons an-
alyzed (n) shown in the bars.
Data shown as mean ± standard error of the mean (SEM). **p < 0.01,
***p < 0.001.competent vesicles may be affected upon loss or doubling
of MeCP2.
Loss or Doubling of MeCP2 Alters the Magnitude
of the RRP without Altering Short-Term Plasticity
We measured RRP size by integrating the charge resulting
from the pulsed application of hypertonic sucrose directly
on the neuron and also computed the presynaptic Pvr to
assess the relative efficiency of synaptic release (see Ex-
perimental Procedures). The data revealed a 41% reduc-
tion in RRP charge in Mecp2Null/y (Figures 2A and 2C) and
a 104% enhancement in RRP charge inMecp2Tg1 neurons
(Figures 2B and 2D) without changes in Pvr (Figures 2E and
Figure 2. Loss or Doubling of MeCP2 Alters the Magnitude of
the RRP, without Altering Short-Term Plasticity and Synaptic
Release Probability
(A and B) Average current response to 4 s application of sucrose from
data shown in (C) and (D).
(C–F) Bar graphs show RRP size (C and D) and Pvr (E and F). Number of
neurons analyzed (n) shown in the bars.
(G and H) Normalized EPSC amplitude with train stimulation.
(I and J) Normalized NMDA-EPSC amplitude with 5 mM MK801. Data
shown as mean ± SEM. **p < 0.01, ***p < 0.001.Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc. 59
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gic Synapse Numbers
(A and B) Representative images of autaptic
neurons show colocalization between MAP2
(green) and VGLUT1 (A) (blue) or PSD95 (B)
(blue). Scale bar, 10 mm.
(C) Bar graph shows synaptic density of each
marker normalized to WT (dotted line).
(D) Representative images showing colocaliza-
tion of VGLUT1 (blue) and PSD95 (red), arrow-
heads, with MAP2 (green). Scale bar, 5 mm.
(E–G) Bar graphs show fraction of colocaliza-
tion for PSD95 (E) and VGLUT1 (F) and synaptic
density of VGLUT1-PSD95 colocalized puncta
(G). Number of neurons analyzed (n) shown in
the bars is the same for WT and corresponding
group.
Data shown as mean ± SEM normalized to WT
(dotted line). *p < 0.05, **p < 0.01, ***p < 0.001.2F). Consistent with no change in Pvr, we found no differ-
ence in EPSC amplitude depression for both Mecp2Null/y
and Mecp2Tg1 neurons (Figures 2G and 2H) upon 10 Hz
train stimulation (see Experimental Procedures). The
effect of 10 Hz train stimulation reflects the efficiency of
presynaptic calcium-triggered release (Schneggenburger
et al., 1999; Zucker and Regehr, 2002). These findings
reveal that loss or doubling of MeCP2 alters RRP size
without affecting presynaptic calcium-dependent release
efficiency.
Loss or Doubling of MeCP2 Does Not
Alter Synaptic Release Probability
RRP size depends on the number of fusion-competent
vesicles per synapse and the number of synapses per
neuron. The number of fusion-competent vesicles per
synapse determines the efficiency of individual synapses
to release a vesicle upon arrival of an action potential, or
synaptic release probability (Pr). Pr can be measured using
the MK801 blocking assay (Hessler et al., 1993; Rose-
nmund et al., 1993) (see Experimental Procedures). The
blocking rate of the NMDA-EPSC amplitude with succes-
sive stimulations of the neuron is proportional to the syn-
aptic release probability, Pr. Since, Pvr is unaltered in
Mecp2Null/y and Mecp2Tg1 neurons, Pr will directly reflect
the number of fusion-competent vesicles per synapse.
We found that Pr is not significantly altered in Mecp2
Null/y
and Mecp2Tg1 hippocampal glutamatergic neurons (Fig-
ures 2I and 2J) compared to respective WT. This study
allowed us to conclude that the number of fusion-compe-
tent vesicles per synapse in Mecp2Null/y and Mecp2Tg160 Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc.neurons are similar to those of WT. This finding suggests
that the observed alterations in the RRP charge upon
either loss or doubling of MeCP2 are most likely due to
changes in the number of glutamatergic synapses per
neuron.
MeCP2 Regulates Glutamatergic
Synapse Numbers
We used immunocytochemistry (see Experimental Proce-
dures) to evaluate glutamatergic synaptic density in au-
taptic neurons. Using microtubule associated protein-2
(MAP2) as a dendritic marker, we found no changes in
dendritic length and branchpoint complexity upon loss
and doubling of MeCP2 during the first 2 weeks of neuro-
nal development (Figures S3A and S3B). To ensure that all
data are collected from glutamatergic neurons, we used
vesicular glutamate transporter-1 (VGLUT1), specific to
glutamatergic neurons for loading glutamate into synaptic
vesicles, as a presynaptic marker (Bellocchio et al., 2000;
Takamori et al., 2000) and postsynaptic density-95
(PSD95), involved in clustering postsynaptic NMDA re-
ceptors at glutamatergic synapse, as a postsynaptic
marker (Cho et al., 1992; Kistner et al., 1993; Kornau
et al., 1995; Niethammer et al., 1996).
First, we evaluated the density of VGLUT1 and PSD95
markers and found that loss of MeCP2 results in a reduc-
tion in the density of both markers and that doubling of
MeCP2 results in an increase in the density of both
markers (Figures 3A–3C). Next, we examined the colocal-
ization of VGLUT1 with PSD95 (VGLUT1-PSD95) to better
assess the density of functional synapses and found that
Neuron
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upon loss of MeCP2 and increased upon doubling of
MeCP2 (Figures 3D–3F). The changes in overall density
of both synaptic markers and the rates of colocalization
between them contribute to a reduction of 39% and an
increase of 60% of colocalized VGLUT1-PSD95 puncta
density compared to WT upon loss or doubling of MeCP2,
respectively.
Physiological and Morphological Phenotypes
Are Restored in Mecp2Null;Tg1
Collins et al. showed behavioral rescue of the Mecp2Null/y
by restoring normal levels of MeCP2 using the human
MECP2 transgene, Mecp2Null;Tg1 (Collins et al., 2004).
We asked whether the rescue could be detected at a cel-
lular and physiological level by examining Mecp2Null/y;Tg1
neurons. Indeed, the amplitude of the EPSC, RRP size,
Pvr, and mEPSC frequency, amplitude, and decay kinetics
were all normalized in Mecp2Null/y;Tg1 neurons (Figure 4A).
Characterization of synaptic density revealed normaliza-
tion of glutamatergic synaptic density (Figures 4B–4E).
These findings show that restoring MeCP2 levels rescues
excitatory synaptic strength and glutamatergic synaptic
densities, which indicate that the effects of either loss or
doubling of MeCP2 on glutamatergic synaptic density
are specific to altered levels of the protein.
Loss or Doubling of MeCP2 Levels Alter
Synapse Numbers in Stratum Radiatum
of Hippocampal CA1
To examine glutamatergic synapse numbers in vivo, we
performed quantitative VGLUT1 and MAP2 immunofluo-
rescence studies in postnatal stratum radiatum (Rad) of
hippocampal CA1 at 2 weeks, a crucial period of synapto-
genesis in vivo (Harris et al., 1992), and 5 weeks, when
symptoms begin to appear inMecp2Null/y mice (see Exper-
imental Procedures). Strikingly, we found at 2 weeks that
VGLUT1 intensity is reduced by 19% and increased by
80% upon loss and doubling of MeCP2, respectively (Fig-
ures 5A–5C and 5E). By 5 weeks, these changes are less
apparent, especially in Mecp2Null/y (Figures 5D and 5E).
No significant differences in total MAP2 intensity for both
Mecp2Null/y and Mecp2Tg1 were observed at both time
points (Figures 5A, 5B, and 5F–5H). These in vivo findings
corroborate the autaptic neuron findings and reveal that
levels of MeCP2 are critical for regulating glutamatergic
synapse numbers during early postnatal development in
vivo. Moreover, the data suggest that compensatory
events occur over time to mask the early changes in syn-
apse numbers.
DISCUSSION
Loss-of-function MECP2mutations cause RTT in females,
and duplication of theMECP2 locus leads to a progressive
neurological syndrome in males. In this study, we reveal
how loss or doubling of MeCP2 levels impacts neuronal
function. First, we demonstrate that MeCP2 function iscritical at a single-neuron level. Second, we provide direct
evidence that MeCP2 levels are critical for synapse forma-
tion in autaptic neurons and in vivo. Third, we uncover
altered synapse number as the earliest morphological
abnormality observed in mouse models of RTT and
MECP2 duplication syndrome. Our discovery that the
in vivo changes in synapse numbers appear early in post-
natal development but disappear over time suggests that
homeostatic compensatory changes occur in response to
the early perturbation of synapse numbers. This finding
highlights the importance of probing the pathogenesis of
Rett syndrome and MECP2 duplication disorders during
the ‘‘presymptomatic’’ stage.
Synaptogenesis is a critical neuronal developmental
process in the first 2 weeks of postnatal development
in vitro (Rao et al., 1998) and in vivo (Harris et al., 1992).
Our findings that glutamatergic synapses are altered in
autaptic neurons and in vivo during the first 2 weeks of de-
velopment indicate that MeCP2 regulates genes required
for the initial formation of synaptic contacts. Whether
Figure 4. Physiological and Morphological Phenotypes Are
Restored in Mecp2Null;Tg1
(A) Bar graph shows EPSC amplitude, RRP charge, and Pvr (WT, n = 65)
and mEPSC frequency, amplitude, and decay (WT, n = 48) normalized
to WT (dotted line).
(B) Representative images showing colocalization of VGLUT1 (blue)
and PSD95 (red), arrowheads, with MAP2 (green). Scale bar, 5 mm.
(C–E) Bar graphs show fraction of colocalization for PSD95 (C) and
VGLUT1 (D) and synaptic density of VGLUT1-PSD95 colocalized
puncta (E).
Number of neurons (n) shown in the bars. Data shown as mean ± SEM.Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc. 61
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Levels Lead to In Vivo Alterations in Syn-
apse Numbers in Stratum Radiation of
Hippocampal CA1
(A and B) Representative images of hippocam-
pal CA1 show MAP2 (red) and VGLUT1 (blue)
at 2 weeks of age. Scale bar, 50 mm. Or, stra-
tum oriens; Pyr, stratum pyramidale; Rad, stra-
tum radiatum.
(C and D) Graphs show VGLUT1 intensity in
Rad.
(E) Bar graph shows VGLUT1 intensity normal-
ized to WT (dotted line).
(F and G) Graphs show MAP2 intensity in Rad.
(H) Bar graph shows MAP2 intensity normal-
ized to WT (dotted line). Number of sections
analyzed (n) for bar graphs is shown in corre-
sponding graphs. Data shown as mean ±
SEM. *p < 0.05, **p < 0.01, ***p < 0.001.MeCP2 also functions in regulating the maintenance of
these synapses in association with neuronal activity re-
mains to be elucidated. The finding that MeCP2 plays
a critical function in regulating neuronal developmental
processes during the first 2 postnatal weeks is consistent
with recent postnatal restoration studies. These studies
showed that neurological impairments associated with
loss of MeCP2 can be reversed by postnatal restoration
of MeCP2 levels (Giacometti et al., 2007; Guy et al.,
2007). Interestingly, however, Giacometti et al. reported
that MeCP2 restoration between 1 to 2 weeks of age
gave the best rescue (Giacometti et al., 2007), which is
consistent with our finding that MeCP2 plays a critical
role in regulating early neuronal development.
We find that alterations of synapse numbers occur prior
to appreciable changes in dendritic complexity of hippo-
campal pyramidal neurons. This is consistent with neuro-
pathological studies from postmortem Rett brains that did
not find significant differences in dendrites of hippocam-
pal CA1 pyramidal neurons (Armstrong et al., 1995) but
found reduced dendritic arborization only in the pyramidal
neurons of layer III and V in frontal, motor, and inferior tem-62 Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc.poral regions (Armstrong et al., 1995; Belichenko et al.,
1997). In another study using rat hippocampal slice
cultures, simplification of the dendritic complexity in the
hippocampus was reported when using either shRNA-
induced knockdown of MeCP2 or knockdown of MeCP2
concomitant with overexpression of wild-type MeCP2
(Zhou et al., 2006). These approaches lead to rapid post-
natal changes in MeCP2 levels, raising the possibility that
the acute changes in MeCP2 levels might contribute to the
observed dendritic abnormalities. Recently, a study by
Guy et al. demonstrated that rapid restoration of MeCP2
function is detrimental to mice, highlighting the fact that
neurons are very sensitive to acute changes in MeCP2
levels (Guy et al., 2007).
In examining mass cultured hippocampal neurons from
Mecp2Null/y, Nelson and colleagues used synaptophysin-1
(Syn1) as a synaptic marker and found no significant
changes in synapse density (Nelson et al., 2006). Because
Syn1 marks the synapses in both excitatory and inhibitory
neurons, their study does not address whether the num-
ber of only excitatory glutamatergic synapses are altered.
We used the synaptic markers VGLUT1 and PSD95, which
Neuron
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ically examine excitatory glutamatergic synapse numbers.
Importantly, we observed correlated reduction in evoked
EPSC response, RRP charge, mEPSC frequency, and glu-
tamatergic synaptic densities with loss of MeCP2. Our re-
sults are consistent with the general view that mEPSC
events are derived from the same quanta composing the
RRP and that these parameters correlate with synaptic
densities (Groemer and Klingauf, 2007).
Although the functional analysis in the autaptic neuron
showed no changes in release probability, short-term
plasticity, or postsynaptic strength, we cannot exclude
the possibility that changes in these parameters occur
during development in vivo and contribute to pathogene-
sis. Release probability and postsynaptic strength in neu-
ronal networks can change in response to perturbations in
excitatory synaptic strength (Davis, 2006; Turrigiano and
Nelson, 2004). Such compensatory changes may be
responsible for the observed changes in short-term plas-
ticity in hippocampal slices from MeCP2-deficient mice
that showed that paired-pulse facilitation, an indicator of
decreased presynaptic release probability, occurred
only in symptomatic 6- to 10-week-old mice, not in pre-
symptomatic mice (Asaka et al., 2006). Asaka and col-
leagues’ discovery that presynaptic release properties ap-
pear unaltered in slices from presymptomatic Mecp2 null
mice is consistent with our data in the autapse and sup-
ports our conclusion that this is not an initial contributor
to disease pathophysiology.
In sum, we provide direct evidence that MeCP2 levels
are central and critical for synapse formation and that
MeCP2 plays an important role at the level of a single neu-
ron and provide evidence for compensatory effects in re-
sponse to the alterations in synapse number in vivo. There
are two additional clinically relevant conclusions that de-
rive from the findings in this study. First, both a decrease
and an increase in synaptic number are associated with
neurological disorders that share several features, includ-
ing autism spectrum phenotypes. Second, given the
emerging evidence that several synaptic proteins are
implicated in autism (Durand et al., 2007; Feng et al.,
2006; Jamain et al., 2003; Zoghbi, 2003), it is possible
that the MeCP2 targets regulating synapse numbers
may be involved in autism pathogenesis. Altogether, these
findings provide an important framework for investigating
the pathogenesis of MECP2 and autism spectrum disor-
ders and a new avenue for exploring potential therapeutic
interventions.
EXPERIMENTAL PROCEDURES
Animals and Neuronal Culture
Mecp2Null/y male mice on a C57BLJ6 background, Mecp2Tg1 male
mice on a FVB background, and Mecp2Null/y;Tg1 rescue mice obtained
by breeding Mecp2Null/+ females to Mecp2Tg1 males were used in this
study. All procedures to maintain and use these mice were approved
by the Institutional Animal Care and Use Committee for Baylor College
of Medicine and Affiliates.For autaptic neuron studies, collagen/poly-D-lysine microislands
were made on an agarose-coated glass coverslip using a custom-built
stamp to achieve uniform size (200 mm diameter) (Bekkers and Ste-
vens, 1991; Pyott and Rosenmund, 2002). WT littermate control and
test group were treated and examined in parallel. Hippocampal neu-
rons from newborn mice were plated at 300/cm2 density in a chemically
defined medium (Neurobasal-A media supplemented with Glutamax
and B-27; Invitrogen).
Electrophysiology of Autaptic Hippocampal Neurons
Only microislands containing a single neuron were used for the exper-
iments. Whole-cell voltage-clamp recordings were performed
between days 7 and 14 in vitro (DIV). Approximately equal numbers
of neurons from the respective groups were measured in parallel. All
data were acquired and analyzed blinded to genotype.
Neurons were clamped at 70 mV with an Axopatch 200B amplifier
(Axon Instruments, Inc.) under control of Clampex 9.2 (Axon Instru-
ments, Inc.). Data were acquired at 10 kHz and low-pass filtered at
5 kHz. Series resistance was compensated at 80%, and only cells
with series resistances below 10 MU were analyzed. Solutions were
applied directly onto the neuron with a fast flow exchange microper-
fusion device (SF-77B, Warner Instruments, Inc.). The patch-pipette
internal solution contained (mM) 146 KCl, 17.8 HEPES, 1 EGTA,
0.6 MgCl2, 4 ATP-Mg, 0.3 GTP-Na, 12 phosphocreatine, and
50 U/ml phosphocreatine kinase. Neurons were bathed in standard ex-
tracellular solution at 300 mOsm, pH 7.4, and containing (mM)
140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 4 CaCl2, and 4 MgCl2.
See Supplemental Experimental Procedures for details in acquiring
EPSC, RRP, mEPSC, short-term plasticity, and MK801 data.
Data were analyzed with Axograph 4.9 or Axograph X (Molecular
Devices and Axograph). Statistical significances were tested using
Student’s t test and nonparametric Mann-Whitney test.
Immunocytochemistry and Image Acquisition of Autaptic
Hippocampal Neurons
Neurons from the respective groups were fixed in parallel at DIV 7–10
with 4% paraformaldehyde and incubated overnight at 4C with sheep
anti-PSD-95 (1:200, Zymed), rabbit anti-VGLUT1 (1:1000, Synaptic
Systems), and mouse anti-MAP2 (1:2000, Chemicon). All images
were acquired and analyzed blinded to genotype. Images were
acquired on a Zeiss 510 laser-scanning confocal microscope with
settings to allow the pixel intensities to remain within the dynamic
range. Measurements were made using ImageJ. VGLUT1 and
PSD95 colocalized if markers directly overlapped or were closely
apposed to each other. Statistical significances were tested using
Student’s t test and nonparametric Mann-Whitney.
Immunohistochemistry and Image Acquisition
of Hippocampal CA1
Two animals were fixed by transcardial perfusion with PBS-buffered
4% paraformaldehyde per genotype and time point. Coronal sections
were obtained by sectioning on a Leica CM3050S cryostat at 40 mm for
2 weeks and 25 mm for 5 weeks. Sections were incubated for 48 hr at
4C with rabbit anti-VGLUT1 (1:1000, Synaptic Systems) and mouse
anti-MAP2 (1:2000, Chemicon). All images were acquired and ana-
lyzed blinded to genotype. Images were acquired on a Zeiss 510 la-
ser-scanning confocal microscope with same settings for laser power
and detector gain for test group and corresponding controls. Statisti-
cal analysis of the integrated intensity plot profiles was analyzed using
Student’s t test.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/56/1/58/DC1/.Neuron 56, 58–65, October 4, 2007 ª2007 Elsevier Inc. 63
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